Renal Biomarkers Market By Biomarker Type (Functional Biomarker (Serum Creatinine, Serum Cystatin C, and Urine Albumin) and Up-regulated Protein (Neutrophil Gelatinase-associated Lipocalin (NGAL), Kidney Injury Molecule-1, and INTERLEUKIN-18)), By Diagnostic Technique (Enzyme-linked Immunosorbent Assay, Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), and Others), By End-user (Hospital, Diagnostic Laboratory, and Other End Users), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI380320 | Publish Date: May 2024 | No. of Pages: 165

Global Renal Biomarkers Market Market Companies

  • Abbott Laboratories
  • BioPorto Diagnostics A/S
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Pacific Biomarkers
  • BioMérieux
  • Beckman Coulter (Danaher Corporation)
  • Randox Laboratories Ltd.
  • Siemens Healthineers.

Recent News:

  • According to PubMed Central article, when there is already a substantial degree of renal impairment that compromises the early use of potentially effective treatment therapies, the biomarkers that are now employed in clinical practice are thought to be relevant. An essential unmet medical need is the development of more precise and sensitive biomarkers to identify CKD early and enhance patient prognoses.